Impact of psychoactive substances on risk of suicide in schizophrenia. Review
Keywords:
suicide, schizophrenia, psychoactive substancesAbstract
The main reason of death among people suffering from schizophrenia is suicide. Suicidal risk in this group of patients still remains at high level and is rated at 10%. Literature of subject points to some essential factors of suicide in schizophrenia, among them are mentioned abusing or addiction to psychoactive substances. The aim of present study is making a survey of current studies, concerning the influence of ingesting psychoactive substances on process of schizophrenia and suicidal behaviors in this group of patients. From analysis of literature results, that using psychoactive substances increases the risk of suicidal attempt in schizophrenia and interaction of this phenomenon is complex as it comes to accumulation variables resulting from coexistence of schizophrenia and disorders connected with using psychoactive substances. The most frequently quoted in literature of subject factors of suicidal risk in schizophrenia are partly located also among these, which are important in abusing and addiction to psychoactive substances. Contemporary news, point to necessity of earliest identification patients with schizophrenia and disorders connected with using psychoactive substances, to introduce effective, two-way and simultaneous therapy of both diseases.
References
1. Petit J.R. Psychiatria ratunkowa. Wrocław: Urban & Partner; 2007; 248-267.
2. Golec S., Kokoszka A. Postępowanie w nagłych zaburzeniach psychicznych. Kraków: Medycyna Praktyczna, 2002; 100-105.
3. Wciórka J. Schizofrenia, zaburzenia schizotypowe i schizoafektywne. In: Bilikiewicz A. Eds. Psychiatria. Wrocław: Urban & Partner 2002; Vol. 2, 213-323.
4. Palmer B.A., Pankratz V.S., Bostwick J.M. The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry, 2005; 62: 247-253.
5. Siris S. Suicide and schizophrenia. J. Psychopharmacol., 2001; 15: 127-35.
6. Pompili M. Suicide risk in schizophrenia: an overview. In: Tatarelli R, Pompili M, Girardi P. eds. Suicide in schizophrenia. New York: Nova Science Publishers 2007; 1-18.
7. Blanchard J.J., Brown S.A., Horan W.P., Sherwood A.R. Substance use disorders in schizophrenia: review, integration and a proposed model. Clin. Psychol. Rev., 2000; 20: 207-234.
8. Cantor-Graae E., Nordstrom L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res., 2001; 1: 48(1), 69-82.
9. Soyka M., Albus M., Immler B., Kathmann N., Hippius H. Psychopathology in dual diagnosis and non-addicted schizophrenics - are there differences? Eur. Arch. Psychiatry Clin. Neurosci., 2001; 251: 232-238.
10. Pużyński S., Rybakowski J. Neurobiologia zaburzeń psychicznych.. In: Bilikiewicz, A. Eds. Psychiatria. Wrocław: Urban & Partner 2002; Vol. 1, 151-178.
11. Dervaux A., Baylé F.J., Laqueille X., Bourdel M., Le Borgne M., Olié J., Krebs M. Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia? Am. J. Psychiatry, 2001; 158: 492-494.
12. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of Current and Lifetime Substance Use in Schizophrenia. Schizophr. Bull., 1998; 24(3): 443-455.
13. Bodkin L.L., Singh A., Corcoran C. Kanabinole jako czynnik ryzyka psychozy u podatnych nastolatków: implikacje terapeutyczne. Psychiatria po Dyplomie 2008; 5, 6: 66-72.
14. Gut-Fayand A., Dervaux A., Olie J.P., Loo H., Poirier M.F., Krebs M.O. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Research, 2001; 102: 65-72.
15. Baran-Furga H., Steinbarth-Chmielewska K. Uzależnienia. Obraz kliniczny i leczenie. Warszawa: Wydawnictwo Lekarskie PZWL 1999; 213-323.
16. Miles H., Johnson S., Amponsah-Afuwape S., Finch E., Leese M., Thornicroft G. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. javascript:AL_get(this, 'jour', 'Psychiatr Serv.'); Psychiatr. Serv., 2003; 54(4): 554-61.
17. Liraud F., Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders. Psychiatry Research, 2000; 93: 63-72.
18. Shoval G., Zalsman G., Apter A., Diller R., Sher L., Weizman A. A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use. Comprehensive Psychiatry, 2007; 48: 1-7.
19. Swadi H., Bobier C. Substance use disorder comorbidity among inpatient youths with psychiatric disorder. Aust. N. Z. J. Psychiatry, 2003; 37: 294-298.
20. Green A.I., Burgess E.S., Dawson R., Zimmet S.V., Strous R.D. Alcohol and cannabis use in schizophrenia: effects of clo-zapine vs. risperidone. Schizophr. Res., 2003; 1: 60(1), 81-5.
21. Altamura A.C., Mundo E., Bassetti R., Green A., Linden-mayer J.P., Alphs L., Meltzer H.Y. Transcultural differences in suicide attempters: Analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder. Schizophr. Res. 2007; 89: 140-146.
22. Malone K.M., Waternaux C., Haas G., Cooper T.B., Li S., Mann J.J. Cigarette Smoking, Suicidal Behavior, and Serotonin Function in Major Psychiatric Disorders. Am. J. Psychiatry, 2003; 160: 773-779.
23. Altamura A.C., Bassetti R., Bigotti S., Pioli R., Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizoph. Res., 2003; 60: 47-55.
24. Limosin F., Loze J.Y., Philippe A., Casadebaig F., Rouillon F. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr. Res., 2007; 94: 23-28.
25. Shoval G., Sever J., Sher L., Diller R., Apter A., Weizman A., Zalsman G. Substance Use, Suicidality, and Adolescent-Onset Schizophrenia: An Israeli 10-Year Retrospective Study. J. Child. Adolesc. Psychopharmacol., 2006; 16, 6, 767-775.
26. Kamali M., Kelly L., Gervin M., Browne S., Larkin C., O’Callaghan E. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr. Scand., 2000; 101: 452-456.
27. Cantwell R. on behalf of the Scottish Comorbidity Study Gropup Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br. J. Psychiatry, 2003; 182: 324-329.
28. Modestin J. Symptoms, subtype, and suicidality in patients with schizophrenia. In: Tatarelli R., Pompili M., Girardi P. eds. Suicide in schizophrenia. New York: Nova Science Publishers 2007; 31-47.
Makara-Studzińska M., Koślak A., Grzywa-Bilkiewicz A. 88
29. Verdoux H., Liraud F., Gonzales B., Assens F., Abalan F., van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr. Scand., 1999; 100(5): 389-95.
30. Kim C.H., Jayathilake K., Meltzer H.Y. Hopelessness, neurocognitive function and insight in schizophrenia. Schizophr. Res., 2003; 60: 71-80.
31. Harkavy-Friedman J.M. Depression and Suicidal Behavior in Schizophrenia. In: Tatarelli R., Pompili M., Girardi P. eds. Suicide in schizophrenia. New York: Nova Science Publishers 2007; 99-112.
32. McGirr A., Turecki G. What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions. Schizophr. Res., 2008; 98: 217-224.
33. McGirr A., Tousignant M., Routhier D., Pouliot L., Chawky N., Margolese H.C., Turecki G. Risk factors for completed sui-cide in schizophrenia and other chronic psychotic disorders: a case-control study. Schizophr. Res. 2006; 84(1): 132-43.
34. Heilä H., Isometsä E.T., Henriksson M.M., Heikkinen M.E., Marttunen M.J., Lönnqvist J.K. Suicide and Schizophrenia: A Nationwide Psychological Autopsy Study on Age- and Sex-Specific Clinical Characteristics of 92 Suicide Victims With Schizophrenia. Am. J. Psychiatry, 1997; 154: 1235-1242.
35. Steinert T., Wiebe C., Gebhardt R.P. Aggressive Behavior Against Self and Others Among First-Admission Patients With Schizophrenia. Psychiatric Services, 1999; 50: 85-90.
36. Harkavy-Friedman J.M., Restifo K., Malaspina D., Kaufmann C.A., Amador X.F., Yale S.A., Gorman J.M. Suicidal Behavior in Schizophrenia: Characteristics of Individuals Who Had and Had Not Attempted Suicide. Am. J. Psychiatry, 1999; 156: 1276-1278.
37. Hawton K., Sutton L., Haw C., Sinclair J., Deeks J.J. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry, 2005; 187: 9-20.
38. Pompili M., Amador X.R., Girardi P., Harkavy-Friedman J., Harrow M., Kaplan K., Krausz M., Lester D., Meltzer H.Y., Modestin J., Montross L.P., Mortensen P.B., Munk-Jorgensen P., Nielsen J., Nordentoft M., Saarinen P.I., Zi-sook S., Wilson S.T., Tatarelli R. Suicide risk in schizophrenia: learning from the past to change the future. Ann. Gen. Psychiatry, 2007; 16: 10, 1-22.
39. Scheller-Gilkey G., Lewine R.R., Caudle J., Brown F.W. Schizophrenia, substance use, and brain morphology. Schizophr. Res., 1999; 11: 35(2), 113-20.
